In this article, dealmaking business, the GS Verde Group examine the state of investment in the UK Health sector, as data from Beauhurst indicates. Exploring the latest investment trends, the UK funding in HealthTech is driving global growth in the sector.
Change accelerated across all sectors during the Covid-19 pandemic, but perhaps none have transformed quite like Healthcare. Digitisation has been expedited, regulatory timelines and strategies have adapted while supply chains, laboratories and manufacturers have had no choice but to tackle newfound complexities. It will come as no surprise that there has been huge global demand for technologically enabled health solutions in the last two years, leading to the rise of the term HealthTech.
A term most often used to describe any technology-enabled solution for out of hospital/general practice healthcare, this technology sector provides a way of adhering to social distancing guidelines while treating and monitoring illnesses, through remote digital health interventions. The UK is driving growth in the global HealthTech sector, with London being a leading hub within the industry. In fact, across the UK and US, over $51.3b in funding was raised for the HealthTech sector in 2021. This total marks a 280% increase since 2016.